Cantharidin Patent Expiration
Cantharidin is Used for treating molluscum contagiosum skin lesions in patients 2 years and older. It was first introduced by Verrica Pharmaceuticals Inc
Cantharidin Patents
Given below is the list of patents protecting Cantharidin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ycanth | US11147790 | Treatment of cutaneous disorders | Aug 22, 2038 | Verrica Pharms |
| Ycanth | US11052064 | Compositions, methods and systems for the treatment of cutaneous disorders | May 28, 2035 | Verrica Pharms |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Cantharidin's patents.
Latest Legal Activities on Cantharidin's Patents
Given below is the list recent legal activities going on the following patents of Cantharidin.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Second letter to regulating agency to determine regulatory review period | 07 Mar, 2024 | US11052064 |
| Letter from FDA or Dept of Agriculture re PTE application | 07 Feb, 2024 | US11052064 |
| Initial letter Re: PTE Application to regulating agency | 06 Dec, 2023 | US11052064 |
| Patent Term Extension Application under 35 USC 156 Filed | 12 Sep, 2023 | US11052064 |
| Recordation of Patent Grant Mailed Critical | 19 Oct, 2021 | US11147790 |
| Patent Issue Date Used in PTA Calculation Critical | 19 Oct, 2021 | US11147790 |
| Email Notification Critical | 30 Sep, 2021 | US11147790 |
| Issue Notification Mailed Critical | 29 Sep, 2021 | US11147790 |
| Application Is Considered Ready for Issue Critical | 22 Sep, 2021 | US11147790 |
| Dispatch to FDC | 22 Sep, 2021 | US11147790 |
Cantharidin's Family Patents
